Sialyltransferases in cancer

[1]  F. dall’Olio.  The sialyl-α2,6-lactosaminyl-structure: Biosynthesis and functional role , 2000, Glycoconjugate Journal.

[2]  Roland Schauer,et al.  Achievements and challenges of sialic acid research , 2000, Glycoconjugate Journal.

[3]  M. Hollingsworth,et al.  Altered expression of sialylated carbohydrate antigens in HT29 colonic carcinoma cells , 1998, Glycoconjugate Journal.

[4]  I. Brockhausen,et al.  Enzymatic basis for sialyl-Tn expression in human colon cancer cells , 1998, Glycoconjugate Journal.

[5]  Kazuro Furukawa,et al.  Expression of α2,8-sialyltransferase (GD3 synthase) gene in human cancer cell lines: high level expression in melanomas and up-regulation in activated T lymphocytes , 1995, Glycoconjugate Journal.

[6]  P. Delannoy,et al.  Multiplex RT-PCR method for the analysis of the expression of human sialyltransferases: application to breast cancer cells , 2004, Glycoconjugate Journal.

[7]  N. Saijo,et al.  Decreased Expression of α2,8 Sialyltransferase and Increased Expression of β1,4 N-Acetylgalactosaminyltransferase in Gastrointestinal Cancers , 2002 .

[8]  T. Tsuruo,et al.  Reduced sialidase expression in highly metastatic variants of mouse colon adenocarcinoma 26 and retardation of their metastatic ability by sialidase overexpression , 2002, International journal of cancer.

[9]  J. Lafitte,et al.  Tumor Necrosis Factor α Increases the Expression of Glycosyltransferases and Sulfotransferases Responsible for the Biosynthesis of Sialylated and/or Sulfated Lewis x Epitopes in the Human Bronchial Mucosa* , 2002, The Journal of Biological Chemistry.

[10]  Erminia Mariani,et al.  Biosynthesis of the cancer-related sialyl-α2,6-lactosaminyl epitope in colon cancer cell lines expressing β-galactoside α2,6-sialyltransferase under a constitutive promoter , 2001 .

[11]  K. Akahane,et al.  Effect of polysialic acid on the tumor xenografts implanted into nude mice , 2001, International journal of cancer.

[12]  H. Chao,et al.  Altered mRNA expression of sialyltransferase in squamous cell carcinomas of the cervix. , 2001, Gynecologic oncology.

[13]  J. Moskal,et al.  Alpha2,6-sialylation of cell-surface N-glycans inhibits glioma formation in vivo. , 2001, Cancer research.

[14]  U. Rutishauser,et al.  Regulation of Cell Adhesion by Polysialic Acid , 2001, The Journal of Biological Chemistry.

[15]  S. Inoue,et al.  Developmental Profile of Neural Cell Adhesion Molecule Glycoforms with a Varying Degree of Polymerization of Polysialic Acid Chains* , 2001, The Journal of Biological Chemistry.

[16]  B. Samyn-Petit,et al.  The human sialyltransferase family. , 2001, Biochimie.

[17]  R. Hughes.  Galectins as modulators of cell adhesion. , 2001, Biochimie.

[18]  S. Deutscher,et al.  The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. , 2001, Cancer research.

[19]  P. Schlag,et al.  Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas. , 2001, Cancer research.

[20]  A. Varki,et al.  Siglecs, sialic acids and innate immunity. , 2001, Trends in immunology.

[21]  P. Lance,et al.  Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro. , 2001, Biochimica et biophysica acta.

[22]  Kazuro Furukawa,et al.  Ganglioside G(D2) in small cell lung cancer cell lines: enhancement of cell proliferation and mediation of apoptosis. , 2001, Cancer research.

[23]  I. Brockhausen,et al.  The Relative Activities of the C2GnT1 and ST3Gal-I Glycosyltransferases Determine O-Glycan Structure and Expression of a Tumor-associated Epitope on MUC1* , 2001, The Journal of Biological Chemistry.

[24]  A. Novick,et al.  Tumor-induced sensitivity to apoptosis in T cells from patients with renal cell carcinoma: role of nuclear factor-kappaB suppression. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  I. Brockhausen,et al.  Pathways of Mucin O-Glycosylation in Normal and Malignant Rat Colonic Epithelial Cells Reveal a Mechanism for Cancer-Associated Sialyl-Tn Antigen Expression , 2001, Biological chemistry.

[26]  S. Marionneau,et al.  ABH and Lewis histo‐blood group antigens in cancer , 2001, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[27]  R. Yu,et al.  Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production. , 2000, Cancer research.

[28]  B. Samyn-Petit,et al.  Cloning, expression and gene organization of a human Neu5Ac alpha 2-3Gal beta 1-3GalNAc alpha 2,6-sialyltransferase: hST6GalNAcIV. , 2000, The Biochemical journal.

[29]  R. Gerardy-Schahn,et al.  Control of NCAM polysialylation by the differential expression of polysialyltransferases ST8SiaII and ST8SiaIV. , 2000, European journal of cell biology.

[30]  R. Yu,et al.  Reduced cell migration, tumor growth and experimental metastasis of rat F‐11 cells whose expression of GD3‐synthase is suppressed , 2000, International journal of cancer.

[31]  D. Santini,et al.  β‐galactoside α2,6 sialyltransferase in human colon cancer: contribution of multiple transcripts to regulation of enzyme activity and reactivity with sambucus nigra agglutinin , 2000, International journal of cancer.

[32]  C. Belluco,et al.  Clinical Correlations of α2,6-Sialyltransferase Expression in Colorectal Cancer Patients , 2000 .

[33]  B. Mania-Farnell,et al.  Overexpression of Murine Pax3 Increases NCAM Polysialylation in a Human Medulloblastoma Cell Line* , 2000, The Journal of Biological Chemistry.

[34]  H. Wada,et al.  Expression of polysialic acid and STX, a human polysialyltransferase, is correlated with tumor progression in non-small cell lung cancer. , 2000, Cancer research.

[35]  T. Hamamoto,et al.  Redefined substrate specificity of ST6GalNAc II: a second candidate sialyl-Tn synthase. , 2000, Biochemical and biophysical research communications.

[36]  Y. Ikehara,et al.  Molecular cloning and genomic analysis of mouse GalNAc alpha2, 6-sialyltransferase (ST6GalNAc I). , 2000, Journal of biochemistry.

[37]  B. Samyn-Petit,et al.  Molecular cloning and functional expression of human ST6GalNAc II. Molecular expression in various human cultured cells. , 2000, Biochimica et biophysica acta.

[38]  Hiromi Ito,et al.  Molecular Cloning and Expression of Mouse GD1α/GT1aα/GQ1bα Synthase (ST6GalNAc VI) Gene* , 2000, The Journal of Biological Chemistry.

[39]  P. Schlag,et al.  Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases , 2000, Gut.

[40]  Kazuro Furukawa,et al.  GD3 Synthase Gene Expression in PC12 Cells Results in the Continuous Activation of TrkA and ERK1/2 and Enhanced Proliferation* , 2000, The Journal of Biological Chemistry.

[41]  Ten Feizi,et al.  Carbohydrate‐mediated recognition systems in innate immunity , 2000, Immunological reviews.

[42]  R. Yu,et al.  Down‐Regulation of GD3 Ganglioside and Its O‐Acetylated Derivative by Stable Transfection with Antisense V , 2000, Journal of neurochemistry.

[43]  I. Brockhausen.  Pathways of O-glycan biosynthesis in cancer cells. , 1999, Biochimica et biophysica acta.

[44]  N. Dohmae,et al.  The relationship between ST6Gal I Golgi retention and its cleavage-secretion. , 1999, Glycobiology.

[45]  R. Poulsom,et al.  An α2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas , 1999 .

[46]  Y. Ikehara,et al.  Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2,6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens. , 1999, Glycobiology.

[47]  Kazuro Furukawa,et al.  Molecular Cloning of Brain-specific GD1α Synthase (ST6GalNAc V) Containing CAG/Glutamine Repeats* , 1999, The Journal of Biological Chemistry.

[48]  M. Palcic,et al.  Molecular cloning, expression and exon/intron organization of the bovine β-galactoside α2,6-sialyltransferase gene , 1999 .

[49]  R. Yu,et al.  Alteration of ganglioside composition by stable transfection with antisense vectors against GD3-synthase gene expression. , 1999, Biochemistry.

[50]  H. Pircher,et al.  Molecular Cloning and Functional Expression of Two Members of Mouse NeuAcα2,3Galβ1,3GalNAc GalNAcα2,6-Sialyltransferase Family, ST6GalNAc III and IV* , 1999, The Journal of Biological Chemistry.

[51]  Kazuro Furukawa,et al.  Molecular Cloning of a Novel α2,3-Sialyltransferase (ST3Gal VI) That Sialylates Type II Lactosamine Structures on Glycoproteins and Glycolipids* , 1999, The Journal of Biological Chemistry.

[52]  F. dall’Olio,et al.  Differential expression of the hepatic transcript of β‐galactoside α2,6‐sialyltransferase in human colon cancer cell lines , 1999 .

[53]  J. Lau,et al.  Cell SurfaceN-Acetylneuraminic Acid α2,3-Galactoside-Dependent Intercellular Adhesion of Human Colon Cancer Cells , 1999 .

[54]  G. Christofori,et al.  Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic β tumor cells , 1999, Nature Medicine.

[55]  K. Lloyd,et al.  Relationship of Glycosyltransferases and mRNA Levels to Ganglioside Expression in Neuroblastoma and Melanoma Cells , 1999, Journal of neurochemistry.

[56]  T. Hamamoto,et al.  Molecular cloning and functional expression of a fifth-type alpha 2,3-sialyltransferase (mST3Gal V: GM3 synthase). , 1998, Biochemical and biophysical research communications.

[57]  Young-Choon Lee,et al.  Cloning and Expression of cDNA for a Human Siaα2,3Galβ1,4GlcNA:α2,8-Sialyltransferase (hST8Sia III) , 1998 .

[58]  H. Rahmann,et al.  Heterogeneous Expression of the Polysialyltransferases ST8Sia II and ST8Sia IV During Postnatal Rat Brain Development , 1998, Journal of neurochemistry.

[59]  Mitsuru Nakamura,et al.  Expression Cloning and Functional Characterization of Human cDNA for Ganglioside GM3 Synthase* , 1998, The Journal of Biological Chemistry.

[60]  M. Fukuda,et al.  Differential and Cooperative Polysialylation of the Neural Cell Adhesion Molecule by Two Polysialyltransferases, PST and STX* , 1998, The Journal of Biological Chemistry.

[61]  L. Hornez,et al.  Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. , 1998, Cancer research.

[62]  Y. Ikehara,et al.  Up-regulation of a set of glycosyltransferase genes in human colorectal cancer. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[63]  T. Kawase,et al.  Expression of the neural cell adhesion molecule in astrocytic tumors , 1998, Cancer.

[64]  R. Kannagi,et al.  Gene expression of fucosyl- and sialyl-transferases which synthesize sialyl Lewisx, the carbohydrate ligands for E-selectin, in human breast cancer. , 1998, International journal of oncology.

[65]  J. Marth,et al.  Immune regulation by the ST6Gal sialyltransferase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[66]  S. Takashima,et al.  Genomic Structure and Promoter Activity of the Mouse Polysialic Acid Synthase (mST8Sia IV/PST) Gene* , 1998, The Journal of Biological Chemistry.

[67]  H. Rahmann,et al.  Polysialic acid on the neural cell adhesion molecule correlates with expression of polysialyltransferases and promotes neuroblastoma cell growth. , 1998, Cancer research.

[68]  Y. Watanabe,et al.  Glycolipid sialyltransferases are enhanced during neural differentiation of mouse embryonic carcinoma cells, P19. , 1997, Biochemical and biophysical research communications.

[69]  G. Rougon,et al.  Cell biology of polysialic acid , 1997, Current Opinion in Neurobiology.

[70]  B. Mann,et al.  Low O‐acetylation of sialyl‐LEx contributes to its overexpression in colon carcinoma metastases , 1997, International journal of cancer.

[71]  P. Delannoy,et al.  Cloning and Expression of cDNA for a Human Gal(β1‐3)GalNAc α2,3‐Sialyltransferase from the CEM T‐Cell Line , 1997 .

[72]  I. Brockhausen,et al.  A Transfected Sialyltransferase That Is Elevated in Breast Cancer and Localizes to the medial/trans-Golgi Apparatus Inhibits the Development of core-2–based O-Glycans , 1997, The Journal of cell biology.

[73]  E. Mariani,et al.  Expression of β-galactoside α2,6-sialyltransferase does not alter the susceptibility of human colon cancer cells to NK-mediated cell lysis , 1997 .

[74]  Young-Choon Lee,et al.  Mouse β-galactoside α2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression , 1997 .

[75]  A. Rebbaa,et al.  α2,6‐Sialyltransferase Gene Transfection into a Human Glioma Cell Line (U373 MG) Results in Decreased Invasivity , 1997, Journal of neurochemistry.

[76]  R. Kannagi,et al.  Altered mRNA expression of specific molecular species of fucosyl‐ and sialyl‐transferases in human colorectal cancer tissues , 1997, International journal of cancer.

[77]  H. Inoue,et al.  α‐2,3‐sialyltransferase type 3N and α‐1,3‐fucosyltransferase type VII are related to sialyl Lewisx synthesis and patient survival from lung carcinoma , 1997 .

[78]  B. Fredette,et al.  Human STX Polysialyltransferase Forms the Embryonic Form of the Neural Cell Adhesion Molecule , 1997, The Journal of Biological Chemistry.

[79]  Y. Chung,et al.  Increased sialyl Lewis A expression and fucosyltransferase activity with acquisition of a high metastatic capacity in a colon cancer cell line. , 1997, British Journal of Cancer.

[80]  J. Taylor‐Papadimitriou,et al.  Comparison of O-Linked Carbohydrate Chains in MUC-1 Mucin from Normal Breast Epithelial Cell Lines and Breast Carcinoma Cell Lines: , 1996, The Journal of Biological Chemistry.

[81]  S. Tsuji,et al.  Molecular cloning and expression of a fifth type of alpha2,8-sialyltransferase (ST8Sia V). Its substrate specificity is similar to that of SAT-V/III, which synthesize GD1c, GT1a, GQ1b and GT3. , 1996, The Journal of biological chemistry.

[82]  Young-Choon Lee,et al.  Molecular Cloning and Expression of Human Gal1,3GalNAc a2,3-Sialyltransferase (hST3Gal II) , 1996 .

[83]  Y. Watanabe,et al.  The molecular cloning and expression of alpha 2,8-sialyltransferase (GD3 synthase) in a rat brain. , 1996, Journal of biochemistry.

[84]  J. Paulson,et al.  Systematic nomenclature for sialyltransferases. , 1996, Glycobiology.

[85]  S. Tsuji,et al.  Molecular Cloning and Genomic Analysis of Mouse Galβ1,3GalNAc-specific GalNAc α2,6-Sialyltransferase* , 1996, The Journal of Biological Chemistry.

[86]  H. Kitagawa,et al.  Molecular Cloning of a Developmentally Regulated N-Acetylgalactosamine 2,6-Sialyltransferase Specific for Sialylated Glycoconjugates (*) , 1996, The Journal of Biological Chemistry.

[87]  K. Colley,et al.  The expression of Galβ1,4GlcNAc α2,6 sialyltransferase and α2,6-linked sialoglycoconjugates in human brain tumors , 1996, Acta Neuropathologica.

[88]  R. Niemelä,et al.  Expression and function of α2,3‐sialyl‐ and α,3/l,4‐fucosyltransferases in colon adenocarcinoma cell lines: Role in synthesis of E‐selectin counter‐receptors , 1995 .

[89]  P. Lance,et al.  Expression and regulation of glycosyltransferases for N-glycosyl oligosaccharides in fresh human surgical and murine tissues and cultured cell lines. , 1995, Clinical science.

[90]  I. Brockhausen,et al.  Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. , 1995, European journal of biochemistry.

[91]  L. Sternberg,et al.  A Human STX cDNA Confers Polysialic Acid Expression in Mammalian Cells (*) , 1995, The Journal of Biological Chemistry.

[92]  K. Krause,et al.  Quantitative lectinhistochemical and immunohistochemical studies on the occurrence of alpha(2,3)‐ and alpha(2,6)‐linked sialic acid residues in colorectal carcinomas. Relation to clinicopathologic features , 1995, Cancer.

[93]  S. Tsuji,et al.  Molecular cloning and characterization of a third type of N-glycan alpha 2,8-sialyltransferase from mouse lung. , 1995, Journal of biochemistry.

[94]  B. Fredette,et al.  Expression cloning of a human polysialyltransferase that forms the polysialylated neural cell adhesion molecule present in embryonic brain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[95]  T. Hamamoto,et al.  Molecular Cloning of Siaα2,3Galβ1,4GlcNAc α2,8-Sialyltransferase from Mouse Brain (*) , 1995, The Journal of Biological Chemistry.

[96]  P. Lollini,et al.  Human Colon Cancer Cell Lines Permanently Expressing α2,6-Sialylated Sugar Chains by Transfection with Rat β-Galactoside α2,6 Sialyltransferase cDNA , 1995 .

[97]  R. Gornati,et al.  Glycosyltransferase activities in human meningiomas. Preliminary results. , 1995, Cancer biochemistry biophysics.

[98]  T. Hamamoto,et al.  Molecular cloning and expression of chick Gal, β1,3GalNAc α2,3-sialyltransferase , 1995 .

[99]  R. Eddy,et al.  Three genes that encode human β-galactoside α2,3-sialyltransferases. Structural analysis and chromosomal mapping studies , 1995 .

[100]  S. Hakomori,et al.  Tumor-associated sialylated antigens are constitutively expressed in normal human colonic mucosa. , 1995, Cancer research.

[101]  O. Berthier‐Vergnes,et al.  Deficiency of ganglioside biosynthesis in metastatic human melanoma cells: relevance of CMP‐NeuAc: LacCer α2‐3 sialyltransferase (GM3 synthase) , 1995, FEBS letters.

[102]  E. Smeland,et al.  Characterization of a promoter region supporting transcription of a novel human β-galactoside α-2,6-sialyltransferase transcript in HepG2 cells☆ , 1995 .

[103]  D. Stéhelin,et al.  High alpha-2,6-sialylation of N-acetyllactosamine sequences in ras-transformed rat fibroblasts correlates with high invasive potential. , 1995, Glycobiology.

[104]  R. Gerardy-Schahn,et al.  Molecular characterization of eukaryotic polysialyltransferase-1 , 1995, Nature.

[105]  G. Hortobagyi,et al.  Sialyl-Tn antigen expression occurs early during human mammary carcinogenesis and is associated with high nuclear grade and aneuploidy. , 1994, Cancer research.

[106]  Y. Chung,et al.  Alterations of O-glycan biosynthesis in human colon cancer tissues. , 1994, Glycobiology.

[107]  K. Takamiya,et al.  Isolation of GD3 synthase gene by expression cloning of GM3 alpha-2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[108]  J. Dennis,et al.  Sialylation and malignant potential in tumour cell glycosylation mutants. , 1994, Glycobiology.

[109]  Y. Watanabe,et al.  Expression cloning of a CMP-NeuAc:NeuAc alpha 2-3Gal beta 1-4Glc beta 1-1'Cer alpha 2,8-sialyltransferase (GD3 synthase) from human melanoma cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[110]  S. Taniguchi,et al.  Metastatic potential of transformed rat 3Y1 cell lines is inversely correlated with lysosomal‐type sialidase activity , 1994, FEBS letters.

[111]  T. Hamamoto,et al.  Cloning and expression of Gal beta 1,3GalNAc-specific GalNAc alpha 2,6-sialyltransferase. , 1994, The Journal of biological chemistry.

[112]  E. Bock,et al.  Transfection of glioma cells with the neural‐cell adhesion molecule NCAM: Effect on glioma‐cell invasion and growth in vivo , 1994, International journal of cancer.

[113]  T. Nishi,et al.  Expression cloning of a GM3-specific alpha-2,8-sialyltransferase (GD3 synthase). , 1994, The Journal of biological chemistry.

[114]  I. Brockhausen,et al.  O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. , 1994, European journal of biochemistry.

[115]  T. Hamamoto,et al.  Cloning and expression of cDNA for a new type of Gal beta 1,3GalNAc alpha 2,3-sialyltransferase. , 1994, The Journal of biological chemistry.

[116]  S. Itzkowitz,et al.  Mucin-associated sialosyl-Tn antigen expression in gastric cancer correlates with an adverse outcome. , 1994, British Journal of Cancer.

[117]  H. Kitagawa,et al.  Cloning of a novel alpha 2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups. , 1994, The Journal of biological chemistry.

[118]  T. Hamamoto,et al.  Molecular cloning and expression of GalNAc alpha 2,6-sialyltransferase. , 1994, The Journal of biological chemistry.

[119]  T. Hamamoto,et al.  Molecular cloning and expression of chick embryo Galβ1,4GlcNAcα2,6‐sialyltransferase , 1994 .

[120]  P. Lackie,et al.  In vitro and in vivo growth of clonal sublines of human small cell lung carcinoma is modulated by polysialic acid of the neural cell adhesion molecule. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[121]  J. Jass,et al.  Monoclonal Antibody Tkh2 To The Cancer‐Associated Epitope Sialosyl Tn Shows Cross‐Reactivity With Variants Of Normal Colorectal Goblet Cell Mucin , 1994, Pathology.

[122]  W. Kemmner,et al.  Enhanced activity of CMP-NeuAc:Galβ1-4GlcNAc:α2,6-sialyltransferase in metastasizing human colorectal tumor tissue and serum of tumor patients , 1993 .

[123]  K. Furukawa,et al.  Genetic and enzymatic basis for the differential expression of GM2 and GD2 gangliosides in human cancer cell lines. , 1993, Cancer research.

[124]  K. Sasaki,et al.  Expression cloning of a novel Gal beta (1-3/1-4) GlcNAc alpha 2,3-sialyltransferase using lectin resistance selection. , 1993, The Journal of biological chemistry.

[125]  T. Hamamoto,et al.  Molecular cloning and expression of Galβ1,3GalNAcα2,3‐sialyltransferase from mouse brain , 1993 .

[126]  H. Kitagawa,et al.  Cloning and Expression of Human Galβ1,3(4)GlcNAc α2,3-Sialyltransferase , 1993 .

[127]  J. Paulson,et al.  Polymerase chain reaction cloning of a developmentally regulated member of the sialyltransferase gene family. , 1993, The Journal of biological chemistry.

[128]  R. Eddy,et al.  Chromosome mapping and organization of the human beta-galactoside alpha 2,6-sialyltransferase gene. Differential and cell-type specific usage of upstream exon sequences in B-lymphoblastoid cells. , 1993, The Journal of biological chemistry.

[129]  D. Treré,et al.  Expression of alpha 2,6-sialylated sugar chains in normal and neoplastic colon tissues. Detection by digoxigenin-conjugated Sambucus nigra agglutinin. , 1993, European journal of histochemistry : EJH.

[130]  J. Paulson,et al.  Cloning and expression of the Gal beta 1, 3GalNAc alpha 2,3-sialyltransferase. , 1992, The Journal of biological chemistry.

[131]  A L Burlingame,et al.  Primary structure of Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase determined by mass spectrometry sequence analysis and molecular cloning. Evidence for a protein motif in the sialyltransferase gene family. , 1992, The Journal of biological chemistry.

[132]  K. Lloyd,et al.  Glycosylation pathways in the biosynthesis of gangliosides in melanoma and neuroblastoma cells: relative glycosyltransferase levels determine ganglioside patterns. , 1992, Cancer research.

[133]  R. Dahiya,et al.  Mucin oligosaccharide biosynthesis in human colonic cancerous tissues and cell lines , 1992, Cancer.

[134]  V. Laudet,et al.  The c-Ha-ras Oncogene Induces Increased Expression of β-Galactoside α-2,6-Sialyltransferase in Rat Fibroblast (FR3T3) Cells , 1992 .

[135]  F. Serafini‐Cessi,et al.  Enhanced CMP‐NeuAc:Galβ1, 4GlcNAc‐R α2, 6 sialyltransferase activity of human colon cancer xenografts in athymic nude mice and of xenograft‐derived cell lines , 1992 .

[136]  V. Laudet,et al.  Comparison of sialyl- and α-1,3-galactosyltransferase activity in NIH3T3 cells transformed with ras oncogene: increased β-galactoside α-2,6-sialyltransferase , 1992 .

[137]  T. Sata,et al.  Expression of alpha 2,6-linked sialic acid residues in neoplastic but not in normal human colonic mucosa. A lectin-gold cytochemical study with Sambucus nigra and Maackia amurensis lectins. , 1991, The American journal of pathology.

[138]  J. Bolscher,et al.  Enzymatic amplification involving glycosyltransferases forms the basis for the increased size of asparagine-linked glycans at the surface of NIH 3T3 cells expressing the N-ras proto-oncogene. , 1991, The Journal of biological chemistry.

[139]  P. Skacel,et al.  Enzymic control of the expression of the X determinant (CD15) in human myeloid cells during maturation: the regulatory role of 6-sialytransferase. , 1991, Blood.

[140]  P. Lackie,et al.  Polysialic acid of the neural cell adhesion molecule distinguishes small cell lung carcinoma from carcinoids. , 1991, The American journal of pathology.

[141]  M. Kaji,et al.  Changes in the ganglioside composition of human neuroblastoma cells under different growth conditions , 1991, International journal of cancer.

[142]  F. dall’Olio,et al.  α2, 6 sialylation of N‐acetyllactosaminic sequences in human colorectal cancer cell lines. Relationship with non‐adherent growth , 1991, International journal of cancer.

[143]  W. Lee,et al.  Enhanced expression of ganglioside GD3 in human and rat hepatocellular carcinoma cells and NIH 3T3 cells transfected with human tumor DNAs. , 1990, Cancer research.

[144]  S. Hakomori,et al.  Sialosyl‐Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients , 1990, Cancer.

[145]  W. Kemmner,et al.  Sialic acid dependent cell adhesion to collagen IV correlates with in vivo tumorigenicity of the human colon carcinoma sublines HCT116, HCT116a and HCT116b. , 1990, Biochemical and biophysical research communications.

[146]  T. Ørntoft,et al.  O‐linked mucin‐type glycoproteins in normal and malignant colon mucosa: Lack of T‐antigen expression and accumulation of tn and sialosyl‐Tn antigens in carcinomas , 1990, International journal of cancer.

[147]  G. Steele,et al.  Inhibition of sialic acid incorporation prevents hepatic metastases. , 1990, Archives of surgery.

[148]  C. Figdor,et al.  Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP-212. , 1990, Cancer research.

[149]  R. Dahiya,et al.  Cell surface sialoprotein alterations in metastatic murine colon cancer cell lines selected in an animal model for colon cancer metastasis. , 1990, Cancer research.

[150]  G. Zettlmeissl,et al.  Complete cDNA sequence encoding human β-galactoside α-2, 6-sialyltransferase , 1990 .

[151]  K. Furukawa,et al.  Sialyltransferase levels and ganglioside expression in melanoma and other cultured human cancer cells. , 1989, Cancer research.

[152]  F. Minni,et al.  Increased CMP‐NeuAc:Galβ1,4GlcNAc‐R α2,6 sialyltransferase activity in human colorectal cancer tissues , 1989 .

[153]  D. Hayes,et al.  Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line. , 1989, Cancer communications.

[154]  S. Hakomori,et al.  Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. , 1989, Advances in cancer research.

[155]  Y. Kim,et al.  Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. , 1989, Cancer research.

[156]  M. Glick,et al.  Extended polysialic acid chains (n greater than 55) in glycoproteins from human neuroblastoma cells. , 1988, The Journal of biological chemistry.

[157]  T. Miyazawa,et al.  Possible mechanism of inhibition of experimental pulmonary metastasis of mouse colon adenocarcinoma 26 sublines by a sialic acid: nucleoside conjugate. , 1988, Cancer research.

[158]  D. Bitter‐Suermann,et al.  Reexpression of poly(sialic acid) units of the neural cell adhesion molecule in Wilms tumor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[159]  A. Ludwig,et al.  Increased expression of Thomsen-Friedenreich antigens during tumor progression in breast cancer patients. , 1988, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[160]  K. McEntee,et al.  Primary structure of beta-galactoside alpha 2,6-sialyltransferase. Conversion of membrane-bound enzyme to soluble forms by cleavage of the NH2-terminal signal anchor. , 1987, The Journal of biological chemistry.

[161]  I. Goldstein,et al.  The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence. , 1987, The Journal of biological chemistry.

[162]  C. Boland,et al.  Comparison of T-antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry. , 1986, Cancer research.

[163]  John G. Collard,et al.  Potential of T-Cell Hybridomas Cell Surface Sialic Acid and the Invasive and Metastatic Updated Version , 2006 .

[164]  S. Toyoshima,et al.  Inhibition of experimental pulmonary metastasis of mouse colon adenocarcinoma 26 sublines by a sialic acid:nucleoside conjugate having sialyltransferase inhibiting activity. , 1986, Cancer research.

[165]  R. Seeger,et al.  Expression of GD2 ganglioside by untreated primary human neuroblastomas. , 1986, Cancer research.

[166]  J. Paulson,et al.  Purification of a Gal beta 1 to 4GlcNAc alpha 2 to 6 sialyltransferase and a Gal beta 1 to 3(4)GlcNAc alpha 2 to 3 sialyltransferase to homogeneity from rat liver. , 1982, The Journal of biological chemistry.

[167]  J. Paulson,et al.  Sialylation of glycoprotein oligosaccharides N-linked to asparagine. Enzymatic characterization of a Gal beta 1 to 3(4)GlcNAc alpha 2 to 3 sialyltransferase and a Gal beta 1 to 4GlcNAc alpha 2 to 6 sialyltransferase from rat liver. , 1982, The Journal of biological chemistry.

[168]  J. Dennis,et al.  Surface sialic acid reduces attachment of metastatic tumour cells to collagen type IV and fibronectin , 1982, Nature.

[169]  E. Deutsch,et al.  Serum sialyltransferase levels as a parameter in the diagnosis and follow-up of gastrointestinal tumors. , 1980, Cancer research.